GX-19

From Wikipedia, the free encyclopedia

GX-19
Vaccine description
TargetSARS-CoV-2
Vaccine typeDNA
Clinical data
Other namesGX-19N
Routes of
administration
Intramuscular
Identifiers
DrugBank

GX-19 is a COVID-19 vaccine candidate developed by Genexine consortium.[1][2][3][4]

It is a DNA-based vaccine that encodes the SARS-CoV-2 spike protein.[5]

Related Articles

Wikiwand AI